Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
DTC.CNthis companyDefence Therapeutics Inc.	CA$0.36	-4×	7.79×	0×	-5.53×	-98.2%	0.0%	0.0%	0.0%	-190.7%	-94.2%	-17.4%	0.49×	0.03×	-12.15×	3.42×	0.0%	2	-5.63	1	C-
BCT.TOBriaCell Therapeutics Corp.	CA$5.49	-0.68×	1.47×	0×	-0.39×	-83.3%	0.0%	0.0%	0.0%	-216.0%	-234.6%	-120.9%	0×	0.27×	0×	2.76×	0.0%	1	-10.15	2	C
HBP.TOHelix BioPharma Corp.	CA$0.90	-34.09×	8.05×	0×	-32.25×	-104.3%	0.0%	0.0%	0.0%	-23.6%	-19.7%	-3.8%	0.29×	-0.92×	-20.22×	0.19×	0.0%	1	-7.69	1	D+
MDNA.TOMedicenna Therapeutics Corp.	CA$0.45	-2.91×	21.45×	0×	-1.99×	-91.3%	0.0%	0.0%	0.0%	-741.7%	-725.4%	0.0%	0.05×	0.26×	0×	1.52×	0.0%	0	-30.04	2	C
ONONCO.NEOnco-Innovations Limited	CA$0.22	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
RKRKV.VRakovina Therapeutics Inc	CA$0.18	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Peer median	—	-2.91×	8.05×	0×	-1.99×	-91.3%	0.0%	0.0%	0.0%	-216.0%	-234.6%	-3.8%	0.05×	0.26×	0×	1.52×	0.0%	1	-10.15	2	—